BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 11578968)

  • 1. The role of Epstein-Barr virus in systemic lupus erythematosus.
    McClain MT; Harley JB; James JA
    Front Biosci; 2001 Oct; 6():E137-47. PubMed ID: 11578968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epstein-Barr virus and systemic lupus erythematosus.
    James JA; Harley JB; Scofield RH
    Curr Opin Rheumatol; 2006 Sep; 18(5):462-7. PubMed ID: 16896283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epstein Barr Virus and Autoimmune Responses in Systemic Lupus Erythematosus.
    Jog NR; James JA
    Front Immunol; 2020; 11():623944. PubMed ID: 33613559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epstein-Barr virus infection induces lupus autoimmunity.
    Harley JB; James JA
    Bull NYU Hosp Jt Dis; 2006; 64(1-2):45-50. PubMed ID: 17121489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of clinical and serological parameters of systemic lupus erythematosus patients with Epstein-Barr virus antibody profile.
    Chougule D; Nadkar M; Rajadhyaksha A; Pandit-Shende P; Surve P; Dawkar N; Khadilkar P; Patwardhan M; Kaveri S; Ghosh K; Pradhan V
    J Med Virol; 2018 Mar; 90(3):559-563. PubMed ID: 28734074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epstein-Barr virus and systemic lupus erythematosus.
    Draborg AH; Duus K; Houen G
    Clin Dev Immunol; 2012; 2012():370516. PubMed ID: 22811739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An increased prevalence of Epstein-Barr virus infection in young patients suggests a possible etiology for systemic lupus erythematosus.
    James JA; Kaufman KM; Farris AD; Taylor-Albert E; Lehman TJ; Harley JB
    J Clin Invest; 1997 Dec; 100(12):3019-26. PubMed ID: 9399948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exposure to Epstein-Barr virus infection is associated with mild systemic lupus erythematosus disease.
    Zandman-Goddard G; Berkun Y; Barzilai O; Boaz M; Blank M; Ram M; Sherer Y; Anaya JM; Shoenfeld Y
    Ann N Y Acad Sci; 2009 Sep; 1173():658-63. PubMed ID: 19758212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reactivation of Epstein-Barr virus in patients with systemic lupus erythematosus.
    Huggins ML; Todd I; Powell RJ
    Rheumatol Int; 2005 Apr; 25(3):183-7. PubMed ID: 14666378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Systemic lupus erythematosus and Epstein-Barr virus].
    Tazi I; Fehri S; Elghrari K; Ouazzani T; Benchemsi N
    East Mediterr Health J; 2009; 15(3):701-8. PubMed ID: 19731786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Investigation of Epstein-Barr virus and herpes simplex virus markers by serological and molecular methods in patients with rheumatoid arthritis and systemic lupus erythematosus].
    Us T; Cetin E; Kaşifoğlu N; Kaşifoğlu T; Akgün Y
    Mikrobiyol Bul; 2011 Oct; 45(4):677-83. PubMed ID: 22090298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased antibody levels to stage-specific Epstein-Barr virus antigens in systemic autoimmune diseases reveal a common pathology.
    Sternbæk L; Draborg AH; Østerlund MT; Iversen LV; Troelsen L; Theander E; Nielsen CT; Jacobsen S; Houen G
    Scand J Clin Lab Invest; 2019; 79(1-2):7-16. PubMed ID: 30727744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-Epstein-Barr virus antibodies in Beijing during 2013-2017: What we have found in the different patients.
    Cui J; Yan W; Xu S; Wang Q; Zhang W; Liu W; Ni A
    PLoS One; 2018; 13(3):e0193171. PubMed ID: 29494658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High prevalence of immunoglobulin A antibody against Epstein-Barr virus capsid antigen in adult patients with lupus with disease flare: case control studies.
    Chen CJ; Lin KH; Lin SC; Tsai WC; Yen JH; Chang SJ; Lu SN; Liu HW
    J Rheumatol; 2005 Jan; 32(1):44-7. PubMed ID: 15630723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic lupus erythematosus in adults is associated with previous Epstein-Barr virus exposure.
    James JA; Neas BR; Moser KL; Hall T; Bruner GR; Sestak AL; Harley JB
    Arthritis Rheum; 2001 May; 44(5):1122-6. PubMed ID: 11352244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Defective control of latent Epstein-Barr virus infection in systemic lupus erythematosus.
    Kang I; Quan T; Nolasco H; Park SH; Hong MS; Crouch J; Pamer EG; Howe JG; Craft J
    J Immunol; 2004 Jan; 172(2):1287-94. PubMed ID: 14707107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epstein-barr virus: environmental trigger of multiple sclerosis?
    Lünemann JD; Kamradt T; Martin R; Münz C
    J Virol; 2007 Jul; 81(13):6777-84. PubMed ID: 17459939
    [No Abstract]   [Full Text] [Related]  

  • 18. Impaired Cytokine Responses to Epstein-Barr Virus Antigens in Systemic Lupus Erythematosus Patients.
    Draborg AH; Sandhu N; Larsen N; Lisander Larsen J; Jacobsen S; Houen G
    J Immunol Res; 2016; 2016():6473204. PubMed ID: 27110576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systematic review and meta-analysis of the sero-epidemiological association between Epstein-Barr virus and rheumatoid arthritis.
    Ball RJ; Avenell A; Aucott L; Hanlon P; Vickers MA
    Arthritis Res Ther; 2015 Sep; 17():274. PubMed ID: 26416719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic lupus erythematosus associated with acute Epstein-Barr virus infection.
    Dror Y; Blachar Y; Cohen P; Livni N; Rosenmann E; Ashkenazi A
    Am J Kidney Dis; 1998 Nov; 32(5):825-8. PubMed ID: 9820454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.